TrialAddiction (Abingdon, England)2024

Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial.

Michael J Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.